Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Psychiatry and Behavioral HealthAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Key substance use and mental health indicators in the United States: results from the 2020 national survey on drug use and health, Center. In: for Behavioral Health Statistics and Quality, Substance Abuse and Mental.Health Services Administration, Rockville, MD2021
- Self-reported medical and nonmedical cannabis use among pregnant women in the United States.JAMA. 2019; 322: 167-169
- Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age.Obstet Gynecol. 2015; 213: 201. e1-201. e10
- Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged women.Am J Obstet Gynecol. 2017; 217: 705-707
- Pregnant women’s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm.J Addiction Med. 2017; 11: 211-216
- Attitudes about marijuana use, potential risks, and legalization: a single-center survey of pregnant women.J Matern Fetal Neonatal Med. 2020; 35: 4635-4643
- A comparison of meconium screening outcomes as an indicator of the impact of state-level relaxation of marijuana policy.Drug Alcohol Depend. 2015; 100: e104-e105
- Impact of marijuana legalization on prevalence of maternal marijuana use and perinatal outcomes.Am J Perinatol. 2020; 37: 59
- Pharmacology and effects of cannabis: a brief review.Br J Psychiatry. 2001; 178: 101-106
- Modes of cannabis administration in the year prior to conception among patients in Northern California.Addictive Behaviors Reports. 2022; 15: 100416
- Cannabis potency and contamination: a review of the literature.Addiction. 2008; 103: 1100-1109
- The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.Hum Reprod Update. 2020; 26: 586-602
- Impact of prenatal cannabis use disorder on perinatal outcomes.J Addiction Med. 2022;
- Prevalence and associated birth outcomes of co-use of cannabis and tobacco cigarettes during pregnancy.Neurotoxicol Teratol. 2018; 68: 84-90
- Association between stillbirth and illicit drug use and smoking during pregnancy.Obstet Gynecol. 2014; 123: 113
- Endocannabinoid functions controlling neuronal specification during brain development.Mol Cell Endocrinol. 2008; 286: S84-S90
- Diagnostic and statistical manual of mental disorders.5th ed. American Psychiatric Association, Washington, DC2013
- DSM-5 cannabis withdrawal syndrome: demographic and clinical correlates in US adults.Drug Alcohol Depend. 2019; 195: 170-177
- Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.JAMA Psychiatr. 2015; 72: 1235-1242
- Behavioral therapies for treatment-seeking cannabis users: a metaanalysis of randomized controlled trials.Eval Health Prof. 2015; 38: 94-114
- Cannabis use and cannabis use disorder.Nat Rev Dis Prim. 2021; 7: 1-24
- Pharmacotherapies for cannabis dependence.Cochrane Database Syst Rev. 2019; 1 (Q20 Q19)
- A comprehensive review of cannabis potency in the United States in the last decade.Biol Psychiatr: Cognitive Neuroscience and Neuroimaging. 2021; 6: 603-606
- Cannabis use during pregnancy in the United States: the role of depression.Drug Alcohol Depend. 2020; 210: 107881
- Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US.JAMA Netw Open. 2021; 4: e2136571
- Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes.J Pediatr. 2018; 197: 90-96
- Maternal lifestyle factors and risk for ventricular septal defects.Birth Defects Res Part A Clin Mol Teratol. 2004; 70: 59-64
- A population based study of gastroschisis: Demographic, pregnancy, and lifestyle risk factors.Teratology. 1994; 50: 44-53
- Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986–2002.J Toxicol Environ Health, Part A. 2006; 70: 7-18
- Marijuana use in pregnancy and pregnancy outcome.Am J Perinatol. 1990; 7: 36-38
- Marijuana use in pregnancy and lactation: a review of the evidence.Obstet Gynecol. 2015; 213: 761-778
- Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy.Aust N Z J Obstet Gynaecol. 1983; 23: 15-19
- Maternal periconceptional illicit drug use and the risk of congenital malformations.Epidemiology. 2009; 20: 60-66
- Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.BMJ Open. 2016; 6: e009986
- The effects of cannabis use during pregnancy on low birth weight and preterm birth: a systematic review and meta-analysis.Am J Perinatol. 2022; (AAM)
- Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes.JAMA. 2019; 322: 145-152
- Birth outcomes of neonates exposed to marijuana in Utero: a systematic review and meta-analysis.JAMA Netw Open. 2022; 5: e2145653
- Maternal marijuana use and adverse neonatal outcomes.Obstecot Gynecol. 2016; 128: 713-723
- Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts.J Perinatol. 2020; 40: 1477-1482
- Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review.Reprod Health. 2020; 17: 1-9
- Association between marijuana use and adverse obstetrical and neonatal outcomes.J Perinatol. 2015; 35: 991-995
- Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.Obstet Gynecol. 2017; 217 (e1–8): 478
- Marihuana use by pregnant women: neurobehavioral effects in neonates.Drug Alcohol Depend. 1980; 6: 415-424
- Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls.Drug Alcohol Depend. 2011; 118: 470-474
- Differential effects on cognitive functioning in 9-to 12-year olds prenatally exposed to cigarettes and marihuana.Neurotoxicol Teratol. 1998; 20: 293-306
- Effects of prenatal marijuana exposure on child behavior problems at age 10.Neurotoxicol Teratol. 2000; 22: 325-336
- Prenatal marijuana and alcohol exposure and academic achievement at age 10.Neurotoxicol Teratol. 2004; 26: 521-532
- Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD study.JAMA Psychiatr. 2021; 78: 64-76
- Association of mental health burden with prenatal cannabis exposure from childhood to early adolescence: longitudinal findings from the adolescent brain cognitive development (ABCD) study.JAMA pediatrics. 2022; 176: 1261-1265
- The association of marijuana use with outcome of pregnancy.Am J Public Health. 1983; 73: 1161-1164
- Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study.J Am Acad Child Adolesc Psychiatry. 2009; 48: 1173-1181
- The Ottawa prenatal prospective study (OPPS): methodological issues and findings—it’s easy to throw the baby out with the bath water.Life Sci. 1995; 56: 2159-2168
- Maternal cannabis use in pregnancy and child neurodevelopmental outcomes.Nat Med. 2020; 26: 1536-1540
- Maternal depression and child psychopathology: a meta-analytic review.Clin Child Fam Psychol Rev. 2011; 14: 1-27
- Prenatal maternal psychopathology and stress and offspring HPA axis function at 6 years.Psychoneuroendocrinology. 2019; 99: 120-127
- Marijuana use by breastfeeding mothers and cannabinoid concentrations in breast milk.Pediatrics. 2018; 142
- Maternal marijuana use during lactation and infant development at one year.Neurotoxicol Teratol. 1990; 12: 161-168
- Marijuana: prenatal and postnatal exposure in the human.NIDA Res Monogr. 1985; 59: 48-60
- ABM clinical protocol# 21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.Breastfeed Med. 2015; 10: 135-141
- Challenges for clinical cannabis and cannabinoid research in the united states.J Natl Cancer Inst Monographs. 2021; 2021: 114-122
- Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use.Drug Alcohol Depend. 2019; 196: 14-20
- Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?.Depress Anxiety. 2017; 34: 1006-1017
- Efficacy and acceptability of cannabinoids for anxiety disorders in adults: a systematic review & meta-analysis.J Psychiatr Res. 2020; 129: 257-264
- Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.Lancet Psychiatr. 2019; 6: 995-1010
- Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.Psychopharmacology (Berl). 2022; 239: 1231-1249
- Association of cannabis with long-term clinical symptoms in anxiety and mood disorders: a systematic review of prospective studies.J Clin Psychiatry. 2018; 79: 2248
- Evidence for use of cannabinoids in mood disorders, anxiety disorders, and PTSD: a systematic review.Psychiatr Serv. 2021; 72: 429-436
- Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis.Can J Public Health. 2021; 112: 49-59
- Recommendations from cannabis dispensaries about first-trimester cannabis use.Obstet Gynecol. 2018; 131: 1031
- Healthcare professionals’ and budtenders’ perceptions of perinatal cannabis use.Am J Drug Alcohol Abuse. 2022; 48: 186-194
Article info
Publication history
Published online: April 26, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
Article Info